COMMUNIQUÉS West-GlobeNewswire

Delaware Imaging Network Offers New Brain Imaging Software in Delaware
29/08/2019
Improves the ability to diagnose neurological conditions. NEWARK, Del., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Delaware Imaging Network (DIN), Delaware’s largest network of outpatient medical imaging centers, which is a [...]
OPKO Completes Pivotal Phase 3 Study for Somatrogon (hGH-CTP), an Investigational Long-Acting Growth Hormone Being Studied for the Treatment of Children With Growth Hormone Deficiency
29/08/2019
MIAMI, Aug. 29, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that the last patient has completed the final visit in the Company’s pivotal Phase 3 study evaluating the safety and efficacy of [...]
La Jolla Pharmaceutical Company Receives European Commission Approval for GIAPREZA™ (angiotensin II)
29/08/2019
SAN DIEGO, Aug. 29, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
Assure Holdings Enters into Joint Venture with Clever Claims to Establish New In-House Billing and Collection Company
29/08/2019
– “Velocity Revenue Cycle” to Serve as Exclusive Billing and Collection Vendor for Assure – DENVER, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a [...]
ChemoCentryx to Present at Two Upcoming Investor Conferences
29/08/2019
MOUNTAIN VIEW, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor [...]
Aeglea BioTherapeutics to Present New 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 SSIEM Symposium
29/08/2019
Management to Host Conference Call at 9:00 a.m. ET on Tuesday, September 3 AUSTIN, Texas, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that [...]
Neutra Corp. Discusses Operations and Objectives in Exclusive NetworkNewsWire Audio Interview
29/08/2019
NEW YORK, Aug. 29, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio -- Neutra Corp. (OTCQB: NTRR) today announces the broadcast of its exclusive audio interview with NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution [...]
HOOKIPA Pharma to Present at Upcoming Investor Conferences in September
29/08/2019
NEW YORK and VIENNA, Austria, Aug. 29, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on [...]
Assure Holdings Reports Second Quarter 2019 Financial Results
29/08/2019
– Q2 2019 Managed Case Volume Increased 109% to Quarterly Record of 1,466 – – Interim CEO John Farlinger Named Permanent CEO – DENVER, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure [...]
Copeland Biosciences Corp. Secures Exclusive Canadian Distribution Rights for CareWear® Wearable Light Therapeutics Systems
29/08/2019
TORONTO, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Copeland Biosciences Corp , an orthopedic treatment company that provides remedies to relieve inflammatory pain with proprietary pharmaceutical and cannabis-based topical [...]
Akari Therapeutics Reports Second Quarter 2019 Financial Results And Highlights Recent Clinical Progress
29/08/2019
- Positive early safety and efficacy data with nomacopan Phase II clinical study in patients with mild-to-moderate bullous pemphigoid (BP) announced April 2019 Phase I/II clinical study in patients with moderate-to- [...]
TRACON Pharmaceuticals to Present at the 2019 Wells Fargo Securities Healthcare Conference
29/08/2019
SAN DIEGO, Aug. 29, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Avid Bioservices to Report Financial Results For First Quarter of Fiscal Year 2020 After Market Close on September 5, 2019
29/08/2019
TUSTIN, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Neos Therapeutics to Present at Two Upcoming September Conferences
29/08/2019
DALLAS and FORT WORTH, Texas, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company utilizing its novel microparticle delivery technology to develop and [...]
Allena Pharmaceuticals to Participate in Upcoming Investor Conferences in September
29/08/2019
NEWTON, Mass., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
Helsinn and Lyfebulb Announce Third Annual Patient-Driven Innovation Summit & Award in Oncology to be held during the 14th Monaco Biennale of Oncology 2020
29/08/2019
Helsinn and Lyfebulb Announce Third Annual Patient-Driven Innovation Summit & Award in Oncology to be held during the 14 th Monaco Biennale of Oncology 2020 The Award recognizes Patient Entrepreneurs demonstrating [...]
ImmuCell Receives FDA Response To First CMC Submission for Re-Tain™
29/08/2019
Second Submission Anticipated Around Q3 2020 PORTLAND, Maine, Aug. 29, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) – a growing animal health company that develops, [...]
BioDelivery Sciences Announces Upcoming Investor Conference Presentations
29/08/2019
RALEIGH, N.C., Aug. 29, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic [...]
Editas Medicine to Participate in Upcoming Investor Conferences
29/08/2019
CAMBRIDGE, Mass., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that management will participate in the following investor conferences in [...]

Pages